by Ludwig Cancer Research Graphical abstract. Credit: Cell (2022). DOI: 10.1016/j.cell.2022.03.030 Natural killer (NK) cells have lately become a hot focus of efforts to develop new immunotherapies. Researchers led by Ludwig Harvard’s Tony Letai, whose team collaborated closely with the Ludwig Harvard Kai Wucherpfennig lab in this study, reported in an April issue of Cell a potentially novel approach...
